ID   G19-4
AC   CVCL_XC65
SY   HB G19-4
DR   CCRID; 4201PAT-CCTCC00045
DR   Wikidata; Q93558233
RX   Patent=US6010902;
RX   PubMed=3084650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9536.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human CD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
RX   PubMed=3084650; DOI=10.4049/jimmunol.136.11.3945;
RA   Ledbetter, Jeffrey A.
RA   June, Carl Howard
RA   Martin, Paul Joseph
RA   Spooner, Connie E.
RA   Hansen, John A.
RA   Meier, Kathryn E.
RT   "Valency of CD3 binding and internalization of the CD3 cell-surface
RT   complex control T cell responses to second signals: distinction
RT   between effects on protein kinase C, cytoplasmic free calcium, and
RT   proliferation.";
RL   J. Immunol. 136:3945-3952(1986).
//
RX   Patent=US6010902;
RA   Ledbetter, Jeffrey A.
RA   Gilliland, Lisa Kim
RT   "Antibody heteroconjugates and bispecific antibodies for use in
RT   regulation of lymphocyte activity.";
RL   Patent number US6010902, 04-Jan-2000.
//